DrugDashboards

Solu-Medrol

methylprednisolone sodium succinate · METHYLPREDNISOLONE SODIUM SUCCINATE 40 mg/mL · Injection, Powder, For Solution · Intramuscular; Intravenous · Pharmacia & Upjohn Company LLC

NDC 00009-0039-28 · 25 VIAL in 1 CARTON / 1 mL in 1 VIAL · NDA · View full market →

The short version

10 companies supply this market — deep enough that no single failure threatens the supply. The brand price has held steady around $6.28 per unit over the past year. Generic versions run $3.58 per unit1.8× cheaper. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want. Historically, drugs in this position went on to a new shortage within 90 days about 0.4% of the time — roughly 3× the typical drug (0.1%).

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$6.28per EAinvoice-surveyed acquisition cost · Aug 19, 2026
  • Medicare Part B pays (ASP+6%)$0.2240per billing unit (5 MG)HCPCS J2919 · Jul 1, 2026
  • Part D plans paid (avg)$10.59per dosage unitgross, before rebates — matched by drug name · 2024
  • Federal ceiling (Big4)$96.74per package of 25X1MLPfizer Inc. · Jan 1, 2026

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$2.50$5.00$7.50May 2013Sep 2026$6.28
34 price points · per EASource: CMS NADAC

Estimated fill cost

WAC per package, as filed
$161.72
Reported to Texas DSHS · 2026 annual filing · Pfizer Inc.

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicare Part B (ASP)

Payment limit per 5 MG
$0.224
HCPCS J2919 · Jul 1, 2026 quarter · typically ASP + 6%

Medicaid spend (2025)

$205,286
25,396 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

10Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • sterile injectable+10

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.4%chance of a new FDA shortage posting for methylprednisolone sodium succinate (injectable) in the next 90 days

sterile injectable · sole-source market · price up 4% YoY

For scale: the typical drug’s chance is about 0.1% — this one is 3× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $83.42 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
NDA011856
TE code
AP
Approval date
Jan 1, 1982
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of methylprednisolone sodium succinate (Injection, Powder, For Solution)

LabelerStrengthFirst seenLast seen
Cardinal Health 107, LLCMETHYLPREDNISOLONE SODIUM SUCCINATE 40 mg/mLJul 15, 2026Sep 3, 2026
Hikma Pharmaceuticals USA Inc.METHYLPREDNISOLONE SODIUM SUCCINATE 1 g/1Jul 15, 2026Sep 3, 2026
Medical Purchasing Solutions, LLCMETHYLPREDNISOLONE SODIUM SUCCINATE 125 mg/2mLJul 15, 2026Sep 3, 2026
Pharmacia & Upjohn Company LLCMETHYLPREDNISOLONE SODIUM SUCCINATE 1 g/mLJul 15, 2026Sep 3, 2026
Pharmacia & Upjohn Company LLCMETHYLPREDNISOLONE SODIUM SUCCINATE 40 mg/mLJul 15, 2026Sep 3, 2026
A-S Medication SolutionsMETHYLPREDNISOLONE SODIUM SUCCINATE 125 mg/2mLJul 15, 2026Sep 2, 2026
Civica, Inc.METHYLPREDNISOLONE SODIUM SUCCINATE 125 mg/1Jul 15, 2026Sep 2, 2026
Civica, Inc.METHYLPREDNISOLONE SODIUM SUCCINATE 40 mg/1Jul 15, 2026Sep 2, 2026
Henry Schein, Inc.METHYLPREDNISOLONE SODIUM SUCCINATE 125 mg/2mLJul 15, 2026Sep 2, 2026
Henry Schein, Inc.METHYLPREDNISOLONE SODIUM SUCCINATE 40 mg/mLJul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.METHYLPREDNISOLONE SODIUM SUCCINATE 40 mg/1Jul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.METHYLPREDNISOLONE SODIUM SUCCINATE 125 mg/1Jul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.METHYLPREDNISOLONE SODIUM SUCCINATE 500 mg/1Jul 15, 2026Sep 2, 2026
Medical Purchasing Solutions, LLCMETHYLPREDNISOLONE SODIUM SUCCINATE 40 mg/mLJul 15, 2026Sep 2, 2026
Pharmacia & Upjohn Company LLCMETHYLPREDNISOLONE SODIUM SUCCINATE 500 mg/mLJul 15, 2026Sep 2, 2026
Pharmacia & Upjohn Company LLCMETHYLPREDNISOLONE SODIUM SUCCINATE 1 g/8mLJul 15, 2026Sep 2, 2026
Pharmacia & Upjohn Company LLCMETHYLPREDNISOLONE SODIUM SUCCINATE 2 g/30.6mLJul 15, 2026Sep 2, 2026
Pharmacia & Upjohn Company LLCMETHYLPREDNISOLONE SODIUM SUCCINATE 500 mg/4mLJul 15, 2026Sep 2, 2026
ProPharma DistributionMETHYLPREDNISOLONE SODIUM SUCCINATE 40 mg/mLJul 15, 2026Sep 2, 2026
ProPharma DistributionMETHYLPREDNISOLONE SODIUM SUCCINATE 125 mg/2mLJul 15, 2026Sep 2, 2026
Remedyrepack Inc.METHYLPREDNISOLONE SODIUM SUCCINATE 125 mg/2mLJul 15, 2026Sep 2, 2026
Remedyrepack Inc.METHYLPREDNISOLONE SODIUM SUCCINATE 125 mg/1Jul 15, 2026Sep 2, 2026
Cardinal Health 107, LLCMETHYLPREDNISOLONE SODIUM SUCCINATE 125 mg/2mLJul 15, 2026Aug 31, 2026
Pharmacia & Upjohn Company LLCMETHYLPREDNISOLONE SODIUM SUCCINATE 125 mg/2mLJul 15, 2026Aug 31, 2026
Sportpharm LLCMETHYLPREDNISOLONE SODIUM SUCCINATE 125 mg/2mLJul 25, 2026Aug 29, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Solu-Medrol — NDC 00009-0039-28," retrieved September 3, 2026, https://drugdashboards.com/drug/00009003928.

Free to cite with attribution — see how the data is put together.